Dr. Robert Sullivan, M.D.
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Years since graduation
- 22
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 339
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
FL license ME103826 -
Internal Medicine Physician
FL license TRN7872
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Orlando Orlando, FL
- Orlando Health Orlando, FL
Medical groups
- Central Florida Kidney Specialists Inc (40 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 339
- Services billed
- 2,306
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 789 | 74 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 745 | 193 |
| Established patient office or other outpatient visit, 30-39 minutes | 151 | 68 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 115 | 105 |
| Dialysis procedure including 1 evaluation | 85 | 22 |
| Hemodialysis procedure with physician evaluation | 81 | 38 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 60 | 39 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 55 | 34 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 39 | 27 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 28 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Calcitriol Other prescribers in Orlando, FL | 79 |
| Furosemide Other prescribers in Orlando, FL | 42 |
| Hydralazine Hcl Other prescribers in Orlando, FL | 37 |
| Lisinopril Other prescribers in Orlando, FL | 32 |
| Amlodipine Besylate Other prescribers in Orlando, FL | 29 |
| Carvedilol Other prescribers in Orlando, FL | 28 |
| Xphozah (tenapanor hcl) | 23 |
| Sevelamer Carbonate Other prescribers in Orlando, FL | 21 |
| Doxazosin Mesylate Other prescribers in Orlando, FL | 20 |
| Potassium Chloride Other prescribers in Orlando, FL | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 73 payments worth $1,571 in total to this clinician.
| Travere Therapeutics, Inc. | $286 |
|---|---|
| Aurinia Pharma U.S., Inc. | $221 |
| Calliditas Therapeutics US Inc. | $196 |
| Vantive US Healthcare LLC | $141 |
| Otsuka America Pharmaceutical, Inc. | $129 |
| Novartis Pharmaceuticals Corporation | $124 |
| Mallinckrodt Hospital Products Inc. | $104 |
| Amgen Inc. | $76.87 |
| Food and Beverage | $1,571 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.